Diarrhoea · patients with Shigella dysentery
It is very uncertain whether oral gentamicin changes diarrhoea at compared with nalidixic acid (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether sulphonamides changes diarrhoea at compared with tetracycline (very low certainty).
1 finding from 1 review
Relapse ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Serious adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Other adverse events ‐ not reported · patients with Shigella dysentery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Diarrhoea · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes diarrhoea on compared with beta‐lactams (very low certainty).
1 finding from 1 review
Relapse · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes relapse ‐ All trials clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
Serious adverse events clinical criteria · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes serious adverse events clinical criteria compared with beta‐lactams (very low certainty).
1 finding from 1 review
Discontinuation of medication due to adverse events · patients with Shigella dysentery
It is very uncertain whether fluoroquinolones changes adverse events leading to discontinuation of treatment compared with beta‐lactams (very low certainty).
1 finding from 1 review
Intervention not reported
Spontaneous bacterial peritonitis · Cirrhotic patients with ascites, without gastro‐intestinal bleeding and no current spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes spontaneous bacterial peritonitis (very low certainty).
1 finding from 1 review
Intervention not reported
Mortality · Cirrhotic patients with ascites, without gastro‐intestinal bleeding and no current spontaneous bacterial peritonitis
It is very uncertain whether the intervention changes mortality (very low certainty).
1 finding from 1 review
Death · patients treated for acute bacterial meningitis
1 finding from 1 review
Death · patients treated for meningococcal meningitis
1 finding from 1 review
Deafness · patients treated for acute bacterial meningitis
1 finding from 1 review
Culture positivity 10 to 48 hours start of treatment · patients treated for acute bacterial meningitis
1 finding from 1 review
Diarrhoea · patients treated for acute bacterial meningitis
1 finding from 1 review
Neutropenia · patients treated for acute bacterial meningitis
1 finding from 1 review